CoChat
Sign Up
Cited by 202Autophagy in Disease and TherapyHereditary Neurological DisordersGlycogen Storage Diseases and Myoclonus

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2

Open access
Ferguson, Cole J., Lenk, Guy M., Meisler, Miriam H.·2009·Human Molecular Genetics
DOI 10.1093/hmg/ddp460PMC PMC2778378
Open this paper in CoChat — free accountOpen PDF

Abstract

Mutations affecting the conversion of PI3P to the signaling lipid PI(3,5)P(2) result in spongiform degeneration of mouse brain and are associated with the human disorders Charcot-Marie-Tooth disease and amyotrophic lateral sclerosis (ALS). We now report accumulation of the proteins LC3-II, p62 and LAMP-2 in neurons and astrocytes of mice with mutations in two components of the PI(3,5)P(2) regulatory complex, Fig4 and Vac14. Cytoplasmic inclusion bodies containing p62 and ubiquinated proteins are present in regions of the mutant brain that undergo degeneration. Co-localization of p62 and LAMP-2 in affected cells indicates that formation or recycling of the autolysosome is impaired. These results establish a role for PI(3,5)P(2) in autophagy in the mammalian central nervous system (CNS) and demonstrate that mutations affecting PI(3,5)P(2) can contribute to inclusion body disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddp460

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Markers of autophagy are elevated in brain from Fig4−/− brain. Total brain homogenates were examined by western blotting with antibodies to components of the autophagy pathway. (A) Accumulation of p62 in mutant brain and spinal cord (left and middle panels); quantitative comparison (right panel). (B) qRT-PCR analysis of p62 transcript, relative to the Tata-binding protein transcript, in total brain RNA. Mean ± SD (n = 3 mice of each genotype, assayed in quadruplicate). (C) Normal levels of p62 protein in non-neural tissues. (D) Elevation of LC3-II in mutant brain. (E) Normal level of LC3-I in mutant brain [short exposure of the film in (D)]. (A)–(C) 30 µg protein per lane; (D)–(E) 50 µg protein per lane.
Figure 1. Markers of autophagy are elevated in brain from Fig4−/− brain. Total brain homogenates were examined by western blotting with antibodies to components of the autophagy pathway. (A) Accumulation of p62 in mutant brain and spinal cord (left and middle panels); quantitative comparison (right panel). (B) qRT-PCR analysis of p62 transcript, relative to the Tata-binding protein transcript, in total brain RNA. Mean ± SD (n = 3 mice of each genotype, assayed in quadruplicate). (C) Normal levels of p62 protein in non-neural tissues. (D) Elevation of LC3-II in mutant brain. (E) Normal level of LC3-I in mutant brain [short exposure of the film in (D)]. (A)–(C) 30 µg protein per lane; (D)–(E) 50 µg protein per lane.CC BY-NC · PubMed Central
Figure 2. Normal levels of proteins involved in initiation and mTOR-mediated regulation of autophagy. (A) beclin-1; (B) mTOR; (C) Ser2448 phospho-mTOR; (D) phosphorylated p70 S6 kinase, a downstream target of mTORC1. Thirty micrograms of protein per lane.
Figure 2. Normal levels of proteins involved in initiation and mTOR-mediated regulation of autophagy. (A) beclin-1; (B) mTOR; (C) Ser2448 phospho-mTOR; (D) phosphorylated p70 S6 kinase, a downstream target of mTORC1. Thirty micrograms of protein per lane.CC BY-NC · PubMed Central
Figure 3. p62 is co-localized with ubiquitin in intracellular inclusion bodies. (A) Two-color immunofluorescence of cortical sections from Fig4−/− mouse demonstrates co-localization of ubiquitin and p62. (B and C) Peroxidase immunostaining detects immunodense cytoplasmic inclusion bodies containing p62 and ubiquitin in mutant brain that are not present in wild-type controls. (D) Ultrastructure (TEM) of Fig4−/− brainstem at 7 days of age. (E) Western blot of soluble protein and 15 000g pellet from brain homogenates prepared in radioimmunoprecipitation buffer. Thirty micrograms of protein per lane.
Figure 3. p62 is co-localized with ubiquitin in intracellular inclusion bodies. (A) Two-color immunofluorescence of cortical sections from Fig4−/− mouse demonstrates co-localization of ubiquitin and p62. (B and C) Peroxidase immunostaining detects immunodense cytoplasmic inclusion bodies containing p62 and ubiquitin in mutant brain that are not present in wild-type controls. (D) Ultrastructure (TEM) of Fig4−/− brainstem at 7 days of age. (E) Western blot of soluble protein and 15 000g pellet from brain homogenates prepared in radioimmunoprecipitation buffer. Thirty micrograms of protein per lane.CC BY-NC · PubMed Central
Figure 4. Accumulation of p62 in reactive astrocytes and neurons of Fig4−/− brain. (A) Immunostaining of cortical sections demonstrates co-localization of p62 and GFAP, an astrocyte marker. (B) p62 accumulation in GFAP-positive Bergmann glia in mutant cerebellum; see also Supplementary Material, Fig. S2. (C) Western blot demonstrates increased abundance of full-length GFAP and degradation products in mutant brain; 30 µg protein per lane. (D) Lack of p62 accumulation in astrocytes in the CA1 region of the hippocampus from Fig4+/+ epileptic brain. (E) Neurons were identified with antibody to the nuclear marker NeuN. Only a small number of NeuN-labeled nuclei are associated with cytoplasmic p62 (insert, arrowheads). (F) Most of the p62 in this section is localized in GFAP-positive astrocytes, as also seen in (A).
Figure 4. Accumulation of p62 in reactive astrocytes and neurons of Fig4−/− brain. (A) Immunostaining of cortical sections demonstrates co-localization of p62 and GFAP, an astrocyte marker. (B) p62 accumulation in GFAP-positive Bergmann glia in mutant cerebellum; see also Supplementary Material, Fig. S2. (C) Western blot demonstrates increased abundance of full-length GFAP and degradation products in mutant brain; 30 µg protein per lane. (D) Lack of p62 accumulation in astrocytes in the CA1 region of the hippocampus from Fig4+/+ epileptic brain. (E) Neurons were identified with antibody to the nuclear marker NeuN. Only a small number of NeuN-labeled nuclei are associated with cytoplasmic p62 (insert, arrowheads). (F) Most of the p62 in this section is localized in GFAP-positive astrocytes, as also seen in (A).CC BY-NC · PubMed Central
Figure 5. p62-containing astrocytes in Fig4−/− brain at 1 week of age. (A) Accumulation of p62 in GFAP-positive astrocytes in the thalamus, which exhibits spongiform degeneration at 1 week of age (3). (B) Accumulation of p62 in white matter tracts around the cerebellar nuclei, a site of extensive spongiform degeneration in older animals. (C) The cortex is unaffected at P7 (3).
Figure 5. p62-containing astrocytes in Fig4−/− brain at 1 week of age. (A) Accumulation of p62 in GFAP-positive astrocytes in the thalamus, which exhibits spongiform degeneration at 1 week of age (3). (B) Accumulation of p62 in white matter tracts around the cerebellar nuclei, a site of extensive spongiform degeneration in older animals. (C) The cortex is unaffected at P7 (3).CC BY-NC · PubMed Central
Figure 6. Accumulation of LAMP-2 in Fig4−/− brain. LAMP-2 is a major component of lysosomal membranes, and is also present in late endosomes and autophagosomes. (A) Western blot demonstrates accumulation of LAMP-2 in mutant brain (left panel) with quantitative comparison (right panel). (B) LAMP-2 is concentrated in GFAP-positive astrocytes and not in NeuN-poistive neurons. (C) Co-localization of LAMP-2 and p62. (D) High-resolution confocal imaging (×180) demonstrates subcellular co-localization of LAMP-2 and p62. (E) In cultured cerebellar granule neurons from Fig4−/− mice, soma and processes (insert) are filled with LAMP-2-positive vacuoles.
Figure 6. Accumulation of LAMP-2 in Fig4−/− brain. LAMP-2 is a major component of lysosomal membranes, and is also present in late endosomes and autophagosomes. (A) Western blot demonstrates accumulation of LAMP-2 in mutant brain (left panel) with quantitative comparison (right panel). (B) LAMP-2 is concentrated in GFAP-positive astrocytes and not in NeuN-poistive neurons. (C) Co-localization of LAMP-2 and p62. (D) High-resolution confocal imaging (×180) demonstrates subcellular co-localization of LAMP-2 and p62. (E) In cultured cerebellar granule neurons from Fig4−/− mice, soma and processes (insert) are filled with LAMP-2-positive vacuoles.CC BY-NC · PubMed Central
Figure 7. Impaired autophagy and astrocytosis in a second mouse mutant affecting PI(3,5)P2. (A) The protein VAC14 binds FIG4 and FAB1 kinase in the molecular complex that regulates PI(3,5)P2 synthesis. The Vac14-L156R mutation (red) in the ingls mutant mouse results in destabilization of the complex and reduced levels of PI(3,5)P2 (2). (B) Elevated levels of p62 and LC3-II in brain homogenates from Vac14-mutant mice. Each lane contains 30 µg of protein. (C) Co-localization of p62 and ubiquitin in ingls cortex. (D) Accumulation of p62 in astrocytes and neurons. (E) Accumulation of LAMP-2 in ingls brain; 30 µg protein per lane.
Figure 7. Impaired autophagy and astrocytosis in a second mouse mutant affecting PI(3,5)P2. (A) The protein VAC14 binds FIG4 and FAB1 kinase in the molecular complex that regulates PI(3,5)P2 synthesis. The Vac14-L156R mutation (red) in the ingls mutant mouse results in destabilization of the complex and reduced levels of PI(3,5)P2 (2). (B) Elevated levels of p62 and LC3-II in brain homogenates from Vac14-mutant mice. Each lane contains 30 µg of protein. (C) Co-localization of p62 and ubiquitin in ingls cortex. (D) Accumulation of p62 in astrocytes and neurons. (E) Accumulation of LAMP-2 in ingls brain; 30 µg protein per lane.CC BY-NC · PubMed Central
Figure 8. Schematic depiction of maturation and resolution of the autophagosome. (A) Proteins that accumulate in brain of pale tremor (Fig4) and ingls (Vac14) mutant mice. (B) Model of maturation of autophagic vesicles, with two potential sites of slowdown or blockage that could explain the accumulation of autophagosome and lysosome marker proteins.
Figure 8. Schematic depiction of maturation and resolution of the autophagosome. (A) Proteins that accumulate in brain of pale tremor (Fig4) and ingls (Vac14) mutant mice. (B) Model of maturation of autophagic vesicles, with two potential sites of slowdown or blockage that could explain the accumulation of autophagosome and lysosome marker proteins.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

Sorted by citations

See all 202

Related

Metadata

Authors
Ferguson, C. J., Lenk, G. M., & Meisler, M. H.
Affiliations
University of Michigan (US)
Corresponding author
Meisler, Miriam H.
ORCID
Venue
Human Molecular Genetics
Publisher
Oxford University Press (OUP)
Published
2009-09-29
Volume
18
Issue
24
Pages
4868-4878
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
DOI
10.1093/hmg/ddp460
PMC
PMC2778378
OpenAlex
W2135384508
Cited by
202
References
44
Citations by year
2026: 5 · 2025: 5 · 2024: 4 · 2023: 14 · 2022: 12 · 2021: 13 · 2020: 13 · 2019: 14 · 2018: 9 · 2017: 15 · 2016: 7 · 2015: 11 · 2014: 20 · 2013: 15 · 2012: 21
FWCI
10.07
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Human Molecular Genetics (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Hartwell Foundation
  • National Institutes of Health
  • National Institute of General Medical Sciences (T 32 GM07863, T32GM007863, R01GM024872, R01-GM24872, T32GM008322)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
Keywords
PI(3,5)P2, autophagy, neurons, astrocytes, FIG4, VAC14, LC3-II, p62, LAMP2, autolysosomes, spongiform degeneration, Charcot-Marie-Tooth disease, amyotrophic lateral sclerosis, inclusion bodies, ubiquitinated proteins, central nervous system
MeSH terms
Phosphoinositide Phosphatases, Amyotrophic Lateral Sclerosis, Animals, Astrocytes, Autophagy, Brain, Inclusion Bodies, Charcot-Marie-Tooth Disease, DNA-Binding Proteins, Flavoproteins, Humans, Mice, Mutant Strains, Microtubule-Associated Proteins, Neurons, Transcription Factors, Up-Regulation, Phosphatidylinositol Phosphates, Ubiquitin, Mice, Transcription Factor TFIIH, Lysosomal-Associated Membrane Protein 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review